This summary was created by AI, based on 1 opinions in the last 12 months.
Experts agree that Xponential Fitness is facing challenges with flat gym memberships and a 13% decrease in shares so far this year. One expert speculates that the weight-loss drug craze may be a contributing factor. Overall, the company is experiencing weaknesses in its performance.
Xponential Fitness is a American stock, trading under the symbol XPOF-N on the New York Stock Exchange (XPOF). It is usually referred to as NYSE:XPOF or XPOF-N
In the last year, 1 stock analyst published opinions about XPOF-N. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Xponential Fitness.
Xponential Fitness was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Xponential Fitness.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Xponential Fitness published on Stockchase.
On 2024-11-21, Xponential Fitness (XPOF-N) stock closed at a price of $14.37.
Gym memberships are flat YOY in this sector. He speculates that the weight-loss drug craze is a/the reason. Shares of this are weak, down from its peak, down 13% so far this year.